Nutrition

CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024

The U.S. CBD consumer health market size was estimated at USD 7.81 billion in 2023 and is projected to surpass…

3 months ago

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or…

3 months ago

NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture

BOSTON and CHESTERFIELD, Mo., Sept. 24, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for…

3 months ago

Vitaquest Says Chewable Tablets Outperform Gummies in Growing Supplement Market

Compared head-to-head, chewable tablets offer better dosage control, absorption, stability, and taste, among other advantagesWest Caldwell, New Jersey--(Newsfile Corp. -…

3 months ago

Vitaquest Says Chewable Tablets Outperform Gummies in Growing Supplement Market

Compared head-to-head, chewable tablets offer better dosage control, absorption, stability, and taste, among other advantagesWest Caldwell, New Jersey--(Newsfile Corp. -…

3 months ago

Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Investigational immunotherapy candidate, VTP-1000, seeks to address significant unmet need in people with celiac disease.An estimated one in 100 people…

3 months ago

Agape ATP Launches ATP2, the Future of Health for Ultimate Vitality and Wellness

Now Enhanced with 76 Essential Minerals, 20 Amino Acids, and Advanced Enzymes to Support Overall Wellness KUALA LUMPUR, MALAYSIA /…

3 months ago

Smart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full Compliance

MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC: SMFL) (“Smart for Life” or the “Company”), a…

3 months ago

Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024

HILLSIDE, NJ / ACCESSWIRE / September 20, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial…

3 months ago

This Week in Health News: 11 Stories You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the latest FDA approvals, health…

3 months ago